Next generation sequencing of extraskeletal myxoid chondrosarcoma

Oncotarget. 2017 Mar 28;8(13):21770-21777. doi: 10.18632/oncotarget.15568.


Extraskeletal myxoid chondrosarcoma (EMC) is an indolent translocation-associated soft tissue sarcoma with a high propensity for metastases. Using a clinical sequencing approach, we genomically profiled patients with metastatic EMC to elucidate the molecular biology and identify potentially actionable mutations. We also evaluated potential predictive factors of benefit to sunitinib, a multi-targeted tyrosine kinase inhibitor with reported activity in a subset of EMC patients. Between January 31, 2012 and April 15, 2016, six patients with EMC participated in the clinical sequencing research study. High quality DNA and RNA was isolated and matched normal samples underwent comprehensive next generation sequencing (whole or OncoSeq capture exome of tumor and normal, tumor PolyA+ and capture transcriptome). The expression levels of sunitinib targeted-kinases were measured by transcriptome sequencing for KDR, PDGFRA/B, KIT, RET, FLT1, and FLT4. The previously reported EWSR1-NR4A3 translocation was identified in all patient tumors; however, other recurring genomic abnormalities were not detected. RET expression was significantly greater in patients with EMC relative to other types of sarcomas except for liposarcoma (p<0.0002). The folate receptor was overexpressed in two patients. Our study demonstrated that similar to other translocation-associated sarcomas, the mutational profile of metastatic EMC is limited beyond the pathognomonic translocation. The clinical significance of RET expression in EMC should be explored. Additional pre-clinical investigations of EMC may help elucidate molecular mechanisms contributing to EMC tumorigenesis that could be translated to the clinical setting.

Keywords: EWSR1-NR4A3; extraskeletal myxoid chondrosarcoma; next generation sequencing.

MeSH terms

  • Adult
  • Aged
  • Calmodulin-Binding Proteins / genetics
  • Chondrosarcoma / genetics*
  • DNA Mutational Analysis
  • DNA-Binding Proteins / genetics
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Connective and Soft Tissue / genetics*
  • Oncogene Proteins, Fusion / genetics
  • Proto-Oncogene Proteins c-ret / genetics
  • RNA-Binding Protein EWS
  • RNA-Binding Proteins / genetics
  • Receptors, Steroid / genetics
  • Receptors, Thyroid Hormone / genetics


  • Calmodulin-Binding Proteins
  • DNA-Binding Proteins
  • EWSR1 protein, human
  • NR4A3 protein, human
  • Oncogene Proteins, Fusion
  • RNA-Binding Protein EWS
  • RNA-Binding Proteins
  • Receptors, Steroid
  • Receptors, Thyroid Hormone
  • Proto-Oncogene Proteins c-ret
  • RET protein, human

Supplementary concepts

  • Chondrosarcoma, Extraskeletal Myxoid